Weight Loss · GLP-1 Therapy · Brandon, FL
FDA-approved GLP-1 receptor agonist for chronic weight management. Clinical trials show average 15% body weight reduction, without surgery.
Semaglutide (brand names Ozempic® and Wegovy®) is an FDA-approved GLP-1 receptor agonist that directly reduces appetite, slows gastric emptying, and improves insulin sensitivity.
Unlike older weight loss medications that worked through stimulants or willpower, semaglutide works at the neurological level, activating GLP-1 receptors in the brain that regulate hunger and satiety. Patients consistently report significant reduction in appetite, reduced food "noise," and feeling full faster. In the STEP clinical trial, patients lost an average of 15% of body weight over 68 weeks. At Florida Aesthetics, all semaglutide programs are physician-supervised with regular check-ins to monitor progress and adjust dosing.
Semaglutide is priced monthly. Costs vary based on dose. Most patients start at a low dose and titrate up over 16–20 weeks.
Weeks 1–4
consultation per month
Most patients
consultation per month
Best value
consultation per month
Ready to Book?
Our physician will evaluate your health history and determine if semaglutide is appropriate for you. Schedule your complimentary consultation.